Insights - This morning, Aldeyra hosted their R&D day, where they discussed their pipeline and upcoming plans. Although no AC data was reported, the company did give color … Continue Reading
Read nowInsights - It seems the market is starting to realize Bellus’ potential as the company touched a 52 week high today on the Canadian listing when it … Continue Reading
Read nowInsights - Today Fennec (FENC) announced a $12.5 million senior loan with the Life Sciences Group at Bridge Bank. The loan will have a maturity date of October 1, … Continue Reading
Read nowInsights - Today, Aldeyra (ALDX) acquired privately company Helio Vision for an all stock deal worth $12.5M, with milestones of up to additional $12.5M. The acquisition adds yet … Continue Reading
Read nowInsights - SBPH is developing inarigivir, an immune activator that boosts the efficacy of the immune system fighting off Hepatitis B. Spring Bank’s candidate has the potential … Continue Reading
MemberInsights - Aldeyra (ALDX) will be reporting results from their first Phase 3 study in allergic conjunctivitis (“AC”) sometime in early 2019 (we expect January). A positive … Continue Reading
Read nowInsights - Today Fennec (FENC) announced that the company initiated its rolling NDA for chemo induced hearing loss in patients 1 month- 18 years of age with localized, solid … Continue Reading
Read now
